Status:
COMPLETED
ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
Lead Sponsor:
Lund University
Conditions:
Antibiotic Resistant Infection
Antibiotic Resistant Strain
Eligibility:
All Genders
Brief Summary
Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas. This study investigates to what exte...
Detailed Description
Samples sent to the department of clinical microbiology in Lund, Sweden for culture of salmonella, shigella, yersinia or campylobacter are also cultured selectively for ESBL. All patients are contact...
Eligibility Criteria
Inclusion
- Travellers diarrhoea
- foreign traveller
Exclusion
- foreign traveller but no symptoms
Key Trial Info
Start Date :
February 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2019
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT03866291
Start Date
February 1 2017
End Date
June 20 2019
Last Update
July 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oskar Ljungquist
Helsingborg, Skåne County, Sweden, 25187